Jane Street
NRXP icon

Jane Street’s NRX Pharmaceuticals NRXP Stock Holding History

Jane Street’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99,900
Closed -$213K – 12639
2026
Q1 		$213K Buy
+99,900
New +$202K ﹤0.01% 10007
2022
Q1 		– Sell
-6,540
Closed -$313K – 10800
2021
Q4 		$313K Buy
6,540
+2,180
+50% +$157K ﹤0.01% 8089
2021
Q3 		$404K Buy
+4,360
New +$567K ﹤0.01% 7670

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street's NRXP Position: Q2 2026 in Review

Jane Street increased its NRX Pharmaceuticals (NRXP) stake by 170% in Q2 2026, buying an estimated $247K and bringing the position to 119,018 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #8088.

Jane Street first reported a position in NRXP in Q1 2021 and has held it in 9 quarters since. The position peaked at $714K in Q3 2021. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Jane Street held 119,018 shares of NRX Pharmaceuticals worth $487K as of Q2 2026.
  • Jane Street bought 74,866 NRX Pharmaceuticals shares in Q2 2026, an estimated $247K.
  • NRX Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8088 holding.
  • Jane Street first reported a position in NRX Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
  • Jane Street's NRX Pharmaceuticals position peaked at $714K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.